PMID- 9640329 OWN - NLM STAT- MEDLINE DCOM- 19980721 LR - 20190721 IS - 0012-1606 (Print) IS - 0012-1606 (Linking) VI - 198 IP - 1 DP - 1998 Jun 1 TI - Disregulation of ocular morphogenesis by lens-specific expression of FGF-3/int-2 in transgenic mice. PG - 13-31 AB - FGF-3, originally named int-2, was discovered as an oncogene frequently activated in mammary carcinomas resulting from the chromosomal integration of the mouse mammary tumor virus (MMTV). Int-2 was later designated FGF-3 based on sequence homology with other members of the fibroblast growth factor (FGF) family. FGF-1 is the prototypical member of the FGF family, and is the only family member which activates all known FGF receptor isoforms. Transgenic mice expressing in the lens a form of FGF-1 engineered to be secreted show premature differentiation of the entire lens epithelium. In contrast, transgenic mice engineered to secrete FGF-2 in the lens do not undergo premature differentiation of the lens epithelium (C. M. Stolen et al., 1997, Development 124, 4009-4017). To further assess the roles of FGFs and FGF receptors in lens development, the alpha A-crystallin promoter was used to target expression of FGF-3 to the developing lens of transgenic mice. The expression of FGF-3 in the lens rapidly induced epithelial cells throughout the lens to elongate and to express fiber cell-specific proteins including MIP and beta-crystallins. This premature differentiation of the lens epithelium was followed by the degeneration of the entire lens. Since FGF-1 and FGF-3 can both activate one FGF receptor isoform (FGFR2 IIIb) that is not activated by FGF-2, these results suggest that activation of FGFR2 IIIb is sufficient to induce fiber cell differentiation throughout the lens epithelium in vivo. Furthermore, transgenic lens cells expressing FGF-3 were able to induce the differentiation of neighboring nontransgenic lens epithelial cells in chimeric mice. Expression of FGF-3 in the lens also resulted in developmental alterations of the eyelids, cornea, and retina, and in the most severely affected transgenic lines, the postnatal appearance of intraocular glandular structures. FAU - Robinson, M L AU - Robinson ML AD - Children's Hospital Research Foundation, Columbus, Ohio 43205, USA. FAU - Ohtaka-Maruyama, C AU - Ohtaka-Maruyama C FAU - Chan, C C AU - Chan CC FAU - Jamieson, S AU - Jamieson S FAU - Dickson, C AU - Dickson C FAU - Overbeek, P A AU - Overbeek PA FAU - Chepelinsky, A B AU - Chepelinsky AB LA - eng GR - EY-06511/EY/NEI NIH HHS/United States GR - EY-10448/EY/NEI NIH HHS/United States GR - EY-10803/EY/NEI NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Dev Biol JT - Developmental biology JID - 0372762 RN - 0 (Aquaporins) RN - 0 (Crystallins) RN - 0 (Eye Proteins) RN - 0 (Fgf3 protein, mouse) RN - 0 (Fibroblast Growth Factor 3) RN - 0 (Membrane Glycoproteins) RN - 0 (Proto-Oncogene Proteins) RN - 0 (RNA, Messenger) RN - 0 (aquaporin 0) RN - 62031-54-3 (Fibroblast Growth Factors) SB - IM MH - Animals MH - Aquaporins MH - Cell Differentiation/physiology MH - Crystallins/genetics MH - Eye/cytology/*embryology MH - Eye Proteins/metabolism MH - Fibroblast Growth Factor 3 MH - Fibroblast Growth Factors/*physiology MH - Gene Expression Regulation, Developmental/*genetics MH - Immunohistochemistry MH - In Situ Hybridization MH - Lens, Crystalline/embryology MH - *Membrane Glycoproteins MH - Mice MH - Mice, Transgenic MH - Morphogenesis/*physiology MH - Phenotype MH - Proto-Oncogene Proteins/*physiology MH - RNA, Messenger/analysis EDAT- 1998/06/26 00:00 MHDA- 1998/06/26 00:01 CRDT- 1998/06/26 00:00 PHST- 1998/06/26 00:00 [pubmed] PHST- 1998/06/26 00:01 [medline] PHST- 1998/06/26 00:00 [entrez] AID - S0012160698988790 [pii] AID - 10.1006/dbio.1998.8879 [doi] PST - ppublish SO - Dev Biol. 1998 Jun 1;198(1):13-31. doi: 10.1006/dbio.1998.8879.